Steven Cohen Zai Lab LTD Transaction History
Point72 Asset Management, L.P.
- $44.6 Billion
- Q2 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Zai Lab LTD stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 252,400 shares of ZLAB stock, worth $7.25 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
252,400
Previous 88,170
186.27%
Holding current value
$7.25 Million
Previous $3.19 Million
177.02%
% of portfolio
0.02%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding ZLAB
# of Institutions
171Shares Held
38.6MCall Options Held
150KPut Options Held
201K-
Capital World Investors Los Angeles, CA6.04MShares$173 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY5.54MShares$159 Million2.97% of portfolio
-
Clearbridge Investments, LLC New York, NY4.01MShares$115 Million0.12% of portfolio
-
Janus Henderson Group PLC London, X02.2MShares$63.2 Million0.04% of portfolio
-
Bamco Inc New York, NY1.59MShares$45.6 Million0.16% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $2.81B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...